Effect of 3 to 5 Years of Scheduled CEA ...

In episode 2 of our Healthy Dialogue on Menopause, Rebecca Thurston, PhD, discusses the lack of clinician training and research investment in menopause, as well as new treatment options. Related Content: Menopause Part 1: Beyond Hormones and Hot Flashes The Menopause Gap in Medic ... Show More

Menopause affects half the population yet is critically understudied and often overlooked or misunderstood by much of the medical profession. In episode 1 of our Healthy Dialogue on Menopause, Rebecca Thurston, PhD, explains the physiology, symptoms, and health risks associated w ... Show More

In part 2 of this Healthy Dialogue on breast cancer, Nancy E. Davidson, MD, discusses changes in screening, the patient journey, and what may lie ahead with advances in AI, cancer vaccines, and preventive medicine. Correction: a previous version of this podcast incorrectly identi ... Show More

Dr. Refky Nicola speaks with Dr. Perry Pickhardt about his study comparing CT colonography and multi-targeted stool DNA testing for colorectal cancer screening. They explore differences in sensitivity, specificity, cost-effectiveness, and strategies to optimize detection while mi ... Show More

<p>Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner. </p> <p><a href= "https://doi.org/10.1148/radiol.220218">¹⁸F-DCFPyL PET/CT for Initially Diagnosed and Biochem ... Show More

Dr. Refky Nicola discusses Y-90 radioembolization for patients with metastatic colorectal cancer with Dr. Daniel Brown.  Survival and Toxicities after 90Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry. Emmons et al. Radiology 2022; 305:228– ... Show More

Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ... Show More

Dr. Iyad Alnahhas interviews Drs. Isaias Hernandez-Verdin and Agusti Alentorn about their recent manuscript entitled: "Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial", pub ... Show More

March is colon cancer awareness month so in today's episode, I discuss oncologic treatment options for colorectal cancer with Dr. Hardeep Phull. Dr. Phull is Medical Director of Oncology at Palomar Health and Clinical Instructor at the University of California San Diego. He gives ... Show More

Colorectal cancer is the fourth most common type of cancer in the UK, with over 40,000 new cases each year. The positive predictive value of Faecal immunochemical testing (FIT) far exceeds that of symptoms and makes FIT an important tool for triaging patients with symptoms sugges ... Show More

In this month's Talk Evidence, Helen Macdonald, The BMJ's research integrity editor, is joined again by Juan Franco, editor in chief of BMJ EBM, and Joe Ross, US research editor. They're straying beyond the pages of The BMJ, and discussing an NEJM paper about colonoscopy for co ... Show More

The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide ... Show More